ReviewNeuro-oncology advances

Reassessing the efficacy of bevacizumab in newly diagnosed glioblastoma: A systematic review and external pseudodata-based analysis.

Giacomo Sferruzza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.